Skip to main content
. 2020 Aug 17;27(1):13–19. doi: 10.4103/sjg.SJG_152_20

Table 3.

Table comparing the secondary outcomes of both the groups

Secondary outcomes Restrictive transfusion group n=112 (%) Liberal transfusion group n=112 (%) P
Packed cells transfused 1.72±1.38 1.96±1.54 0.22*
FFP transfused 1.04±2.45 1.57±2.62 0.12*
In-hospital bleeding (%) 12 (10.71) 9 (8) 0.25
Bleeding during follow up (%) 13 (12.26) 14 (13.21) 0.84
Banding (%) 37 (62) 39 (81) 0.99
Sclerosant (%) 4 (7) 4 (8) 1.00
Sengstaken Blakemore tube placement (%) 4 (3.6) 9 (8) 0.29
Propranolol (%) 20 (33.3) 19 (39.6) 0.25
Octreotide (%) 35 (31.25) 50 (44.64) 0.04
Duration of octreotide (days) 2.49±0.82 2.16±0.77 0.33*
Mean length of admission (days) 3.21±2.78 2.73±1.29 0.10*
Mean Hb at the time of death (g/dl) 7.17±1.85 5.27±2.71 0.19*

FFP: fresh frozen plasma; Hb: Hemoglobin; *independent t-test; Chi-square test